CN106344859A - 一种鹿花盘胸部护理组合物 - Google Patents
一种鹿花盘胸部护理组合物 Download PDFInfo
- Publication number
- CN106344859A CN106344859A CN201610926948.9A CN201610926948A CN106344859A CN 106344859 A CN106344859 A CN 106344859A CN 201610926948 A CN201610926948 A CN 201610926948A CN 106344859 A CN106344859 A CN 106344859A
- Authority
- CN
- China
- Prior art keywords
- cornu cervi
- radix
- fructus
- oil
- breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 7
- 241000282994 Cervidae Species 0.000 title abstract description 13
- 210000003056 antler Anatomy 0.000 title abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 20
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 13
- 235000008434 ginseng Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241000196324 Embryophyta Species 0.000 claims abstract description 12
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 12
- 239000002552 dosage form Substances 0.000 claims abstract description 5
- 239000003921 oil Substances 0.000 claims description 19
- 241000180649 Panax notoginseng Species 0.000 claims description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000341 volatile oil Substances 0.000 claims description 13
- 241000208340 Araliaceae Species 0.000 claims description 12
- 230000000844 anti-bacterial effect Effects 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 6
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- -1 patch Substances 0.000 claims description 4
- 240000007436 Cananga odorata Species 0.000 claims description 3
- 235000007571 Cananga odorata Nutrition 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- 238000005374 membrane filtration Methods 0.000 claims description 3
- 229940060184 oil ingredients Drugs 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 2
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 239000010642 eucalyptus oil Substances 0.000 claims description 2
- 229940044949 eucalyptus oil Drugs 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 229960003639 laurocapram Drugs 0.000 claims description 2
- 229940041616 menthol Drugs 0.000 claims description 2
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 238000003672 processing method Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- OXHNLMTVIGZXSG-UHFFFAOYSA-N 1-Methylpyrrole Chemical compound CN1C=CC=C1 OXHNLMTVIGZXSG-UHFFFAOYSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 37
- 239000008280 blood Substances 0.000 abstract description 28
- 210000004369 blood Anatomy 0.000 abstract description 28
- 239000003814 drug Substances 0.000 abstract description 21
- 210000004185 liver Anatomy 0.000 abstract description 21
- 210000000038 chest Anatomy 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 14
- 210000000481 breast Anatomy 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 238000000034 method Methods 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 8
- 208000004396 mastitis Diseases 0.000 abstract description 8
- 206010006187 Breast cancer Diseases 0.000 abstract description 5
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 5
- 235000013399 edible fruits Nutrition 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 5
- 210000005075 mammary gland Anatomy 0.000 abstract description 5
- 241000736199 Paeonia Species 0.000 abstract description 3
- 206010010356 Congenital anomaly Diseases 0.000 abstract description 2
- 241000208682 Liquidambar Species 0.000 abstract description 2
- 235000006552 Liquidambar styraciflua Nutrition 0.000 abstract description 2
- 206010051131 Mastoptosis Diseases 0.000 abstract description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 2
- 206010020718 hyperplasia Diseases 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 230000036560 skin regeneration Effects 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 4
- 241000382455 Angelica sinensis Species 0.000 abstract 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000002075 main ingredient Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 24
- 230000001737 promoting effect Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000035922 thirst Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 230000002087 whitening effect Effects 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 244000241257 Cucumis melo Species 0.000 description 4
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000001012 protector Effects 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 244000252230 Artemisia stelleriana Species 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010006242 Breast enlargement Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 208000002260 Keloid Diseases 0.000 description 3
- 206010023330 Keloid scar Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 201000008275 breast carcinoma Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000001117 keloid Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 235000006793 Artemisia stelleriana Nutrition 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Chinese gallotannin Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical group CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000006413 coastal sagewort Nutrition 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000013583 drug formulation Substances 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229940043263 traditional drug Drugs 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- ICWHTQRTTHCUHW-IPYPFGDCSA-N 2-[(3s,5r,6r)-6,10-dimethylspiro[4.5]dec-9-en-3-yl]propan-2-ol Chemical compound C[C@@H]1CCC=C(C)[C@]11C[C@@H](C(C)(C)O)CC1 ICWHTQRTTHCUHW-IPYPFGDCSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- ICWHTQRTTHCUHW-UHFFFAOYSA-N Agarospirol Natural products CC1CCC=C(C)C11CC(C(C)(C)O)CC1 ICWHTQRTTHCUHW-UHFFFAOYSA-N 0.000 description 1
- QQUHMASGPODSIW-UHFFFAOYSA-N Albiflorin Natural products C=1C=CC=CC=1C(=O)OCC12C(=O)OC3(C)CC(O)C1CC32OC1OC(CO)C(O)C(O)C1O QQUHMASGPODSIW-UHFFFAOYSA-N 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 241000132003 Atractylis Species 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 241000283026 Cervus elaphus Species 0.000 description 1
- 241000283007 Cervus nippon Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000142952 Hamamelidaceae Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 240000005308 Juniperus chinensis Species 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 241000735234 Ligustrum Species 0.000 description 1
- 241000893545 Liquidambar formosana Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010026889 Mastitis postpartum Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 241000124449 Paeonia obovata Species 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 206010033888 Paraphilia Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 244000044283 Toxicodendron succedaneum Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 240000006023 Trichosanthes kirilowii Species 0.000 description 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 description 1
- 241000975594 Trichosanthes rosthornii Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000004810 Vascular dementia Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- LDHJVCCWWXVXBN-DNJQJEMRSA-N [(3as,5ar,8ar,8bs)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl n-methylsulfamate Chemical compound C([C@H]1OC(C)(C)O[C@H]11)O[C@]2(COS(=O)(=O)NC)[C@H]1OC(C)(C)O2 LDHJVCCWWXVXBN-DNJQJEMRSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- QQUHMASGPODSIW-ICECTASOSA-N albiflorin Chemical compound O([C@@]12C[C@H]3[C@H](O)C[C@@]1(OC(=O)[C@]32COC(=O)C=1C=CC=CC=1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QQUHMASGPODSIW-ICECTASOSA-N 0.000 description 1
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000003667 hormone antagonist Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000009835 oxypaeoniflora Substances 0.000 description 1
- FCHVXNVDFYXLIL-QYDSDWLYSA-N oxypaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@@]1(C[C@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=C(O)C=C1 FCHVXNVDFYXLIL-QYDSDWLYSA-N 0.000 description 1
- RLXWQODPAWIVOI-UHFFFAOYSA-N oxypaeoniflorin Natural products OCC1OC(OC23CC4C5(O)CC2OC(O5)C34COC(=O)c6ccc(O)cc6)C(O)C(O)C1O RLXWQODPAWIVOI-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000007391 self-medication Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008337 systemic blood flow Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000008727 tongluo Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种鹿花盘胸部护理组合物,包括以下质量份数的原料:鹿花盘0.01‑10份,三七0.1‑10份,当归1‑8份,人参0.1‑8份,葛根1‑10份和植物精华成分1‑6份,还可以添加药学上可接受的辅料制成各种剂型。以现代工艺制备的鹿花盘活性成分(蛋白)或超微粉为原料,配伍功效显著的三七、当归、人参、葛根等植物精粹作为主要成分,适当添加女贞子、路路通、瓜蒌、赤芍、天花粉、苍术、柴胡、山药、牡丹根、蒲公英等道地药材,充分增强鹿花盘在保护女性胸部方面的作用:内在活血通络、化瘀行气、滋补肝肾,固人体先天之本,强化生命动力来源;外在止痛、抗菌、消炎,促进皮肤再生;可以丰胸、防止乳房下垂,还能有效防治乳腺增生、乳腺炎、乳腺癌等症。
Description
技术领域
本发明涉及一种鹿花盘胸部护理组合物,属于中药技术领域。
背景技术
鹿是珍贵的药用动物之一,我国是世界上最早将鹿产品作为药用的国家。鹿的药用产品鹿茸、鹿胎、鹿鞭等具有很高的药用价值;但长期以来研究者注意力更多集中在鹿茸的研究方面,而鹿花盘的药用价值则经常被忽视。鹿花盘是雄性梅花鹿或者马鹿锯茸后骨化次年春季自然脱落的平环状残角。历代本草记载,鹿花盘具有温补肝肾,活血消肿,强筋壮骨,软坚散结,益肾下乳的功效;可治疗阴症疮疡,乳痈初起,淤血肿痛等症状,亦可用于乳腺增生,妇女产后乳腺炎的预防和治疗,同时具有催乳作用。近代药理学研究表明,鹿花盘具有显著地抑制乳腺增生的效果,促进免疫细胞的免疫功能,使增生和坏死的乳腺上皮细胞、乳肿液得到消除,抑制乳腺癌的生长。鹿花盘内服用于预防及治疗乳腺增生或者乳腺炎已有文字记载和实践,但是进行外用则鲜有报道或者研究。
中药经皮吸收有着悠久的使用历史,在原始人类中,处于动物本能利用自然界的原始物质对某些病痛实行自发的治疗,以缓解痛苦,如冷水浇洗退热,用冰雪止血、止痛、消肿等,用树叶、草茎涂敷伤口以消肿痛,这些原始的方法,可以说是透皮给药的萌芽。对于透皮给药的机理,清代名医徐灵胎曾谓“用膏贴之,闭塞其气,使药性从毛孔而入其腠理,通经贯络,或提而出之,或功而散之,较之服药尤有力,此至妙之法也。“这一段论述已较明确地阐述了药物头皮吸收的机理。现代研究表明,通过皮肤敷贴方式给药,药物经皮、肤毛细血管吸收后,进入全身血液循环并达到有效血药浓度,从而达到预防或治疗疾病的目的这一透皮吸收方式有很多优点:避免肝脏的首过效应和对胃肠道的破坏,血药浓度持久可控,增加药物的生物利用度;患者可自己用药,出现问题可及时停药,使用方便;避免注射用药的痛苦,避免多次给药,增加病人的耐受性。但是药物穿透皮肤时遇到很多障碍,皮肤的自身条件、药物的理化性质、制剂处方的组成等均影响药物透皮吸收效果。鹿花盘的活性成分以此方式作用于人体胸部的临床实践则有研究的积极意义。
众所周知,乳腺增生是女性最常见的乳房疾病,而该病发病率呈逐年上升的趋势,年龄也越来越低龄化。乳腺增生是指乳腺上皮和纤维组织增生,经常表现为乳房胀痛和乳房肿块,疼痛常见为单侧或双侧乳房胀痛或触痛,周期性疼痛,月经前期发生或加重;内服的治疗药物有多种,但多是抗激素类、雄性激素类或者催乳素药物,虽有一定疗效,但是治疗周期长,容易反复发作,副作用大。如果在内服鹿花盘治疗胸部问题的同时进行外用治疗则双管齐下,效果更佳。
发明内容
目的:为了克服现有技术中存在的不足,本发明提供一种鹿花盘胸部护理组合物,可以补肾通络,软件散结、活血化瘀,防治乳腺炎、乳腺增生、乳腺脓肿及乳腺癌等乳腺疾病,美胸护胸。
技术方案:为解决上述技术问题,本发明采用的技术方案为:
一种鹿花盘胸部护理组合物,其特征在于,包括以下质量份数的原料:鹿花盘0.01-10份,三七0.5-10份,当归1-8份,人参0.5-8份,葛根1-10份和植物精华成分1-6份。
所述的鹿花盘胸部护理组合物,其特征在于:植物精华成分包括以下质量份数的原料:女贞子2-8份,路路通1-8份,瓜蒌1-8份,赤芍1-8份,天花粉1-8份,苍术1-8份,柴胡1-8份,高良姜油0.1-6份;或者山药2-8份,木瓜2-8份,牡丹根2-8份,依兰花油0.1-6份,蔷薇花油0.1-6份。
所述的鹿花盘胸部护理组合物,其特征在于:原料鹿花盘的处理方法为:鹿花盘经过挑选,清洗,干燥后可经气流粉碎机得到D90≤45μm的鹿花盘超微粉;或者采用将鹿花盘超微粉进一步采用酶解法、盐提法、热回流浸提法等提取出鹿花盘蛋白(多肽)。作为优选方案,鹿花盘蛋白可以用0.3mol /L NaCl,20 mmol /L Na2HPO4缓冲液( pH 值为9) 进行提取,料液比为1∶ 12-15,提取时间为8-24h,提取3次,然后4000 r /min 离心30 min,上清液用0.45 μm 滤膜过滤或者灭菌,滤液进行浓缩,浓缩液-20℃预冻,冻干即得到鹿花盘蛋白。
原料处理方法为:三七、人参、当归、葛根、女贞子、路路通、瓜蒌、赤芍、天花粉、苍术、柴胡、山药、木瓜、牡丹根分别按照相应配方中的比例,分别进行处理,清洗,晒干或烘干,粉碎,即可获得或进一步用气流粉碎机得到D90≤45μm的超微粉;或者用醇提或水提提取即可。作为优选方案,所述烘干为用微波85℃以下干燥烘干或用烘箱60℃以下烘干。
本发明鹿花盘胸部护理组合物可加入下列促渗剂中的一种或者二种及以上:荜澄茄油,桉叶油,薄荷醇,肉桂挥发油,丁香挥发油,辛夷挥发油,白芥子挥发油,蛇床子油,干姜挥发油,高良姜挥发油,冰片,月桂氮卓酮,尼速特、油酰聚异二醇甘油脂、亚油酰聚异二醇甘油脂、卡必醇、肉豆蔻、聚乙二醇脂肪酸甘油脂、丙二醇,N-甲基吡洛烷酮。
本发明鹿花盘胸部护理组合物可加入制备不同剂型所需的各种常规辅料,如润滑剂、抑菌剂等,以常规药物制剂方法,直接或间接加入药学上可接受的辅料,制成可常用的粉剂,水剂、凝胶剂、乳剂、膏霜剂、贴剂、油剂、精油和手工皂在内的外用制剂。
有益效果:本发明提供的鹿花盘胸部护理组合物,以现代工艺制备的鹿花盘活性成分或超微粉为原料,配伍功效显著的三七、当归、人参、葛根等植物精粹作为主要成分,适当添加女贞子,路路通,瓜蒌,赤芍、天花粉、苍术、柴胡、山药、牡丹根等道地药材,汇聚了动植物精华的现代结晶,充分增强鹿花盘在保护女性胸部的作用:内在活血通络、化瘀行气、滋补肝肾,固人体先天之本,强化生命动力来源;外在止痛、抗菌、消炎、修复,促进皮肤再生,可以丰胸、防止乳房下垂,还能有效防治乳腺增生、乳腺炎、乳腺癌等症。本发明采用先进工艺萃取出精华活性成分,最大限度地萃取出动植物的精华;同时特别添加含中药成分的复合型促透剂,大大提高有效成分的透皮吸收,充分发挥活性成分对女士胸部的乳腺疾病进行预防和治疗的同时,还可以对胸部皮肤起到增加弹性,美白滋养的作用,是一款融合现代科技成果的的中药配方胸部护理品,非常适合现代爱美人士的个性需求。
具体实施方式
下面实施例对本发明作更进一步的说明。
一种鹿花盘胸部护理组合物,其特征在于配方包含基础成分:鹿花盘2-10份,三七1-8份,当归1-8份人参1-8份,葛根1-10份和植物精华成分1-6份,其中植物精华成分由以下重量组份数的原料组成:女贞子2-8份,路路通1-8份,瓜蒌1-8份,赤芍1-8份,天花粉1-8份,苍术1-8份,柴胡1-8份,高良姜油0.1-6份;或者由山药2-8份,木瓜2-8份,牡丹根2-8份,依兰花油0.1-6份,蔷薇花油0.1-6份组成。而配方中的主要原料简述如下:
鹿花盘:盘别名“花盘”、“角盘”、“珍珠盘”、“鹿角盘”,是鹿科动物的角冠和残留的角根于翌年新茸萌发时自然脱落的部分。具有温补肝肾,活血消肿,强筋壮骨,软坚散结,益肾下乳的功效;可治疗阴症疮疡,乳痈初起,淤血肿痛等症状。
三七:为五加科多年生草本植物三七的干燥根,广西等地多为栽培品,又名山漆、金不换、田七、血参、滇三七,味甘,微苦,性温;具有散瘀止血,消肿定痛,去瘀生新之功效,主治咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌仆肿痛。现代研究表明,三七具有活血止血,造血,降血压降血脂,抗心律失常,镇静镇痛保肝护肾,抗炎等作用;三七还可作用于瘢痕疙瘩表面,软化瘢痕疙瘩,缓解、消除瘙痒、疼痛,使瘢痕结缔组织崩解,从而去除已经形成的各种新老疤痕;同时抑制瘢痕疙瘩的增生、蔓延。
人参:性平、味甘、微苦,微温;归脾、肺经、心经。具有大补元气,复脉固脱,补脾益肺,生津止渴,安神益智的功效。现代研究表明人参含多种皂甙、多糖类成分、氨基酸、维生素和矿物质,护肤品或者外用品中具有促进皮下毛细血管的血液循环,增加皮肤的营养供应,调节皮肤水分平衡,增加皮肤的弹性,抑制黑色素,延缓皮肤衰老,从而使皮肤光泽,柔嫩,洁白。
当归:别名干归、秦哪、西当归、岷当归、金当归、当归身等,甘、辛、苦,温。归肝、心、脾经。 具有补血活血,调经止痛,润燥滑肠的功效。主治血虚诸证,月经不调,经闭,痛经,癥瘕积聚,崩漏,虚寒腹痛,痿痹,肌肤麻木,肠燥便难,赤痢后重,痈疽疮疡,跌扑损伤。现代研究表明具有 补血活血,抗缺氧, 调节机体免疫功能,具有抗癌作用,护肤美容, 抑菌抗炎、抗动脉硬化,抗心律失常,降血脂,抗血栓,抑制血小板聚集等作用。
葛根:为豆科植物野葛的干燥根,习称野葛,别名,葛条,甘葛,葛藤,味甘,性辛,凉;具有解肌退热,透疹,生津止渴,升阳止泻之功。常用于表证发热,项背强痛,麻疹不透,热病口渴,阴虚消渴,热泻热痢,脾虚泄泻。现代研究表明,含多种黄酮类成分,可促进新陈代谢,加强肝脏解毒功能,防止酒精对肝脏的损伤;对高血脂形成的冠状动脉硬化,通过改善心肌缺血状态,防治冠心病、心绞痛、心肌梗塞等心血管疾病;对高血脂形成的脑动脉硬化,通过改善脑缺血状态,防治脑梗塞、偏瘫、血管性痴呆等脑血管疾病;强化肝胆细胞自身免疫功能,抵抗病毒入侵;降血糖,具有延缓衰老、调节血脂血糖、促进造血功能等多方面作用。葛根中的丰富黄酮类物质和葛根素促进皮肤白皙、光润、细腻,使女性焕发青春光彩;内含异黄酮(又叫植物雌激素),它不仅具有使乳腺丰满坚挺和乳房组织重构的作用,而且对子宫、卵巢和皮肤也有作用。野葛根中的异黄酮成分,不仅具有有效的抗乳腺癌作用,而且还有预防心血管疾病的功能。
赤芍:别名木芍药、草芍药、红芍药、毛果赤芍,为植物赤芍或川赤芍的干燥根。味,性寒,归肝经。具有清热凉血,活血祛瘀的功效,是著名野生道地中药材,应用历史悠久,用量较大、用途广泛,主治瘀滞经闭,疝瘕积聚,腹痛,胁痛,衄血,血痢,肠风下血,目赤,痈肿。赤芍的主要成分包括芍药甙、芍药内酯甙、氧化芍药甙、苯甲酰芍药甙、芍药吉酮、芍药新甙、胡萝卜甙,此外,还含有赤芍精即d-儿茶精以及没食子鞣质、苯甲酸等。现代医学研究表明具有清热、镇痛、镇静、解痉挛以及抗惊厥的作用,具有改善心肺功能的作用,它可以扩张冠状动脉,增加冠状动脉血的流量而有抗动脉粥样硬化的作用;同时赤芍有抗病原微生物的作用,赤芍甙有抗炎作用,赤芍能够抑制血小板聚集、抗血栓的形成;有抑制迟发性变态反应的作用,能够降低血糖,保护肝脏,抗肿瘤作用及抗缺氧作用。
女贞子:别名女贞实、冬青子、蜡树、鼠梓子,为木犀科植物女贞Ligustrumlucidum Ait.的干燥成熟果。味甘、苦,性凉,归肝、肾经;具有补益肝肾,明目,清虚热的功效,主治头晕目眩,须发早白,视物昏花,阴虚发热。
路路通:别名枫香果、九孔子、狼目,为金缕梅科植物枫香树Liquidambarformosana Hance 的干燥成熟果序。味苦,性平,归肝、肾经;具有祛风活络,利水通经之功效,用于关节痹痛,麻木拘挛,水肿胀满,乳少经闭。
瓜蒌:别名天撤、苦瓜、山金匏、药瓜皮,本品为葫芦科植物栝楼Trichosantheskirilowii Maxim. 或双边栝楼Trichosan-thes rosthornii Harms 的干燥成熟果实。味甘、微苦,性寒;归肺、胃、大肠经。具有清热涤痰,宽胸散结,润燥滑肠的功效。用于肺热咳嗽,痰浊黄稠,胸痹心痛,结胸痞满,乳痈(乳腺炎),肺痈,肠痈肿痛,大便秘结。
天花粉:别名天花粉,栝楼根,花粉,楼根,白药,瑞雪,天瓜粉,屎瓜根,栝蒌粉,蒌粉,为葫芦科植物栝蒌的根,味甘、微苦,性微寒;归肺、胃经。具有清热泻火,生津止渴,排脓消肿的功效,主治热病口渴、消渴、黄疸、肺燥咳血、痈肿、痔痿。
苍术:菊科植物茅苍术或北苍术的干燥根茎,味苦,性辛、温;归脾、胃、肝经。具有燥湿健脾,祛风散寒,明目的功效,用于脘腹胀满,泄泻水肿,脚气痿躄,风湿痹痛,风寒感冒,夜盲。现代研究表明苍术主要有效成分是以β-桉叶醇及茅术醇为代表的挥发油,具有抗溃疡,调整胃肠运动功能,抑菌,保肝的作用。
柴胡:别名地熏、茈胡、山菜,始载于《神农本草经》,列为上品。性微寒、味苦、辛、归肝经、胆经,具透表泄热,疏肝解郁,升举阳气之功效,主治肝郁气滞,胸肋胀痛,脱肛,子宫脱落,月经不调。现代研究表明,其成分主要含柴胡皂苷(saikosapoins a、 b、 c、 d 四种),甾醇,挥发油(柴胡醇、丁香酚等),脂肪酸(油酸、亚麻油酸、棕榈酸、硬脂酸等)和多糖等。具有解热,抗炎,促进免疫功能,抗肝损伤和辐射损伤的作用。
山药:即薯蓣,别名怀山药 、淮山药 、土薯、山薯、山芋、玉延,为薯蓣科植物薯蓣的干燥根茎,味甘,性平。归脾、肺、肾经。具有补脾养胃,生津益肺,补肾涩精的功效,用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。元代脾胃专家李杲说:“治皮肤干燥以此物润之。“李时珍写到:“山药能润皮毛。“山药对滋养皮肤,健美养颜有独特疗效。
木瓜:别名万寿果、乳瓜,性温,味酸;归肝、脾经。具有舒筋活络,和胃化湿的功效。现代研究表明,木瓜性温不寒不燥,可以使人体吸收的营养更加充分,让皮肤变得光洁柔嫩,减少皱纹让面色更加红润,具有美白、丰胸等美容功效。木瓜含有大量的胡萝卜素,胡萝卜素食一种天然的抗氧化剂,能有有效对抗破坏的身体细胞;同时具有保肝抗菌的作用等。
依兰花油:具有独特浓郁的芳香气味,用于高血压,阳痿早泄性冷淡,可美白皮肤,乌亮头发,促进皮肤的再生及除皱,平衡皮肤油脂,促使乳房丰满 ,减轻忧郁不安。
蔷薇花油:主要成分为香叶醇、香草醇和黄芪苷等,性凉,味甘,具有清暑、和胃、止血的功效。常用于治疗暑热吐血、口渴、泻痢、疟疾、刀伤出血等病证。
本发明可加入制备不同剂型所需的各种常规辅料,以常规药物制剂方法,直接或间接加入药学上可接受的辅料,制成可常用的水剂、粉剂、凝胶剂、乳剂、膏霜剂、贴剂、油剂、精油和手工皂在内的一系列外用制剂产品。
适应人群:希望美胸护胸的爱美人士。
使用方法:晚上入睡前配合胸部按摩使用,可根据个体情况和爱好灵活选择适合自己的剂型。
实施例1
鹿角蛋白胸部精华乳膏(鹿角蛋白即鹿花盘蛋白)
配方:A相:硬脂酸12g、单硬脂酸甘油酯4g、液体石蜡15g、羊毛脂2g、
B 相:鹿花盘活性蛋白3.0g、植物混合提取物(三七8份、人参6份、葛根6份、当归6份、女贞子2份,路路通8份,瓜蒌8份,赤芍4份,天花粉4份,苍术1份,柴胡1份)3g,高良姜油0.1g、甘油10g、三乙醇胺2g、尼泊金甲酯0.1g、适量蒸馏水至100g
制备方法:(一)原料的处理
1、鹿花盘经过挑选,清洗,干燥后可经气流粉碎机得到D90≤45μm的鹿花盘超微粉;将鹿花盘超微粉用0.3mol /L NaCl,20 mmol /L Na2HPO4缓冲液( pH 值为9) 进行提取,料液比为1:15,提取时间为12h,提取3次,然后4000 r /min 离心30 min,上清液用0.45 μm 滤膜过滤,浓缩,浓缩液-20℃预冻,冻干即得到鹿花盘蛋白。
2、按照配方中的比例准确称取三七、人参、当归、葛根、女贞子、路路通、瓜蒌、赤芍、天花粉、苍术、柴胡的重量,分别进行处理,清洗,烘干,粗粉碎,进一步用气流粉碎机得到D90≤45μm的超微粉;将混合超微粉末加水提取2次,每次加10倍混合粉末重量的水,提取30min,合并滤液,减压浓缩至适量体积。
(二)成品的制备
首先将A相高良姜油、硬脂酸、单硬脂酸甘油酯、液体石蜡共置干燥搅拌锅内,水浴加热至50℃~80℃使全熔。然后将B 相鹿花盘蛋白,植物提取物、甘油、尼泊金甲酯、三乙醇胺、适量蒸馏水置另一搅拌锅中,加热至50℃~80℃左右。最后将含有药材的混合物逐渐加入油相混合物中,边加边搅拌均匀至室温,即得。
适应人群:希望美胸护胸的爱美人士。
使用方法:晚上入睡前配合胸部按摩使用。
实践证明,实施例所得的鹿花盘护胸精华乳膏能够活血通络,化瘀行气止痛,抗菌消炎,促进皮肤再生,有效预防和治疗女性的乳腺增生,乳腺炎等胸部不适。
实施例2
鹿花盘胸部抑菌护理液
配方:鹿花盘0.5份、女贞子1份、路路通1份、瓜蒌1份、赤芍2份、天花粉2份、苍术1份、柴胡1份、葛根1份、人参0.5份、当归1份、胶原蛋白1份、高良姜油0.5份、抑菌剂0.0001份。
按照配方比例,以本发明中和药学上常用的提取方法,获得各中药原料的提取液,添加混匀,最后加入抑菌剂,充分搅拌均匀后灌装,即可获得鹿花盘胸部抑菌护理液(喷剂)。
使用方法:每日2-3次,每次喷涂2-3下,涂抹均匀。
主要作用:抑菌、消炎、活血、化瘀,预防乳腺疾病。
以上所述仅是本发明的优选实施方式,应当指出:对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (9)
1.一种鹿花盘胸部护理组合物,其特征在于,包括以下质量份数的原料:鹿花盘0.01-10份,三七0.1-10份,当归1-8份,人参0.1-8份,葛根1-10份和植物精华成分1-6份。
2.根据权利要求1所述的鹿花盘胸部护理组合物,其特征在于:植物精华成分包括以下质量份数的原料:女贞子2-8份,路路通1-8份,瓜蒌1-8份,赤芍1-8份,天花粉1-8份,苍术1-8份,柴胡1-8份,蒲公英1-8份,高良姜油0.1-6份;或者山药2-8份,木瓜2-8份,牡丹根2-8份,依兰花油0.1-6份,蔷薇花油0.1-6份。
3.根据权利要求1所述的鹿花盘胸部护理组合物,其特征在于:原料鹿花盘的处理方法为:鹿花盘挑选,清洗,干燥(冻干或烘干)后可经气流粉碎机得到D90≤45μm的超微粉;或者采用将鹿花盘超微粉进一步采用酶解法、盐提法、热回流浸提法等提取出鹿花盘蛋白(多肽)。
4.根据权利要求3所述的鹿花盘胸部护理组合物,其特征在于:鹿花盘超微粉用0.3mol/L NaCl,20 mmol /L Na2HPO4缓冲液进行提取,料液比为1∶10-20,提取时间为8-24h,提取3-5次,然后4000 r /min 离心25-50 min,上清液用0.45 μm滤膜过滤或者灭菌,滤液进行浓缩,浓缩液-20℃预冻,冻干即得到鹿花盘蛋白。
5.根据权利要求2所述的鹿花盘胸部护理组合物,其特征在于,原料处理方法:三七、人参、当归、葛根、女贞子、路路通、瓜蒌、赤芍、天花粉、苍术、柴胡、山药、木瓜、牡丹根分别按照相应配方中的比例,分别进行处理,清洗,晒干或烘干,粉碎,即可获得或进一步用气流粉碎机得到D90≤45μm的超微粉;或者用醇提或水提提取即可。
6.根据权利要求1所述的鹿花盘胸部护理组合物,其特征在于:所述烘干为用微波85℃以下干燥烘干或用烘箱60℃以下烘干;所述冻干为低温冷冻干燥。
7.根据权利要求1所述的鹿花盘胸部护理组合物,其特征在于:还包括下列促渗剂中的一种或者几种:荜澄茄油,桉叶油,薄荷醇,肉桂挥发油,丁香挥发油,辛夷挥发油,白芥子挥发油,蛇床子油,干姜挥发油,高良姜挥发油,冰片,月桂氮卓酮,尼速特、油酰聚异二醇甘油脂、亚油酰聚异二醇甘油脂、卡必醇、肉豆蔻、聚乙二醇脂肪酸甘油酯、丙二醇,N-甲基吡洛烷酮。
8.根据权利要求1所述的鹿花盘胸部护理组合物,其特征在于:还包括制备不同剂型所需的药学上可接受的辅料/添加剂,如润滑剂、抑菌剂等。
9.根据权利要求1所述的鹿花盘胸部护理组合物,其特征在于:所述鹿花盘胸部护理组合物为粉剂、水剂、凝胶剂、乳剂、膏霜剂、贴剂、油剂、精油和手工皂在内的外用制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610926948.9A CN106344859A (zh) | 2016-10-31 | 2016-10-31 | 一种鹿花盘胸部护理组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610926948.9A CN106344859A (zh) | 2016-10-31 | 2016-10-31 | 一种鹿花盘胸部护理组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106344859A true CN106344859A (zh) | 2017-01-25 |
Family
ID=57863966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610926948.9A Pending CN106344859A (zh) | 2016-10-31 | 2016-10-31 | 一种鹿花盘胸部护理组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106344859A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106943314A (zh) * | 2017-05-17 | 2017-07-14 | 秀瑞斯(天津)科技有限公司 | 胸部舒缓配方、制备方法及使用方法 |
CN107362101A (zh) * | 2017-08-30 | 2017-11-21 | 臧子宜 | 一种丰胸美胸组合物、乳膏及制备方法、使用方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1846723A (zh) * | 2005-04-05 | 2006-10-18 | 魏自彬 | 鹿花盘软胶囊及其制造方法 |
CN103330823A (zh) * | 2013-05-31 | 2013-10-02 | 刘涛 | 一种治疗乳腺增生的中药制剂及其制备方法 |
CN105106852A (zh) * | 2015-09-17 | 2015-12-02 | 李朕 | 一种治疗乳腺增生及乳腺癌的中药制剂 |
-
2016
- 2016-10-31 CN CN201610926948.9A patent/CN106344859A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1846723A (zh) * | 2005-04-05 | 2006-10-18 | 魏自彬 | 鹿花盘软胶囊及其制造方法 |
CN103330823A (zh) * | 2013-05-31 | 2013-10-02 | 刘涛 | 一种治疗乳腺增生的中药制剂及其制备方法 |
CN105106852A (zh) * | 2015-09-17 | 2015-12-02 | 李朕 | 一种治疗乳腺增生及乳腺癌的中药制剂 |
Non-Patent Citations (1)
Title |
---|
黄萍等: "鹿角托盘总蛋白的提取工艺研究", 《安徽农业科学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106943314A (zh) * | 2017-05-17 | 2017-07-14 | 秀瑞斯(天津)科技有限公司 | 胸部舒缓配方、制备方法及使用方法 |
CN107362101A (zh) * | 2017-08-30 | 2017-11-21 | 臧子宜 | 一种丰胸美胸组合物、乳膏及制备方法、使用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102049008B (zh) | 一种治疗黄褐斑的中药组合物及其制备方法 | |
CN103202789A (zh) | 一种植物源生发白转黑洗发剂及其制备方法 | |
CN105125466A (zh) | 一种祛斑晚霜及其制备方法 | |
CN103202790A (zh) | 纯天然洗发剂 | |
CN105232911A (zh) | 一种中药组合物 | |
CN106265438A (zh) | 中药杏仁美容面膜 | |
CN101711804B (zh) | 一种治疗白癜风病的中药膏 | |
CN105288597A (zh) | 一种治疗皮肤色素沉着的药物 | |
CN102274309B (zh) | 头发毛囊改造剂及其制备方法 | |
CN106344859A (zh) | 一种鹿花盘胸部护理组合物 | |
CN107744569A (zh) | 一种具有养发、生发功效的精华液及其制备方法 | |
CN101336970A (zh) | 用于治疗和防止白发、脱发的中草药 | |
CN103751762B (zh) | 一种促进肌肤细胞重组并能延缓衰老的产品 | |
CN105342954A (zh) | 一种具有活肤化瘀去黄去斑的中药面膜及其制备方法 | |
CN103054073B (zh) | 一种养颜鱼鳞冻及其制备方法 | |
CN106389136A (zh) | 植物纳米乳痤疮膏 | |
CN109439473B (zh) | 一种祛斑美容皂及其制备方法 | |
CN107198727A (zh) | 一种美容养颜活血调经的药物组合物及其制备方法 | |
CN105362807A (zh) | 一种具有活肤化瘀去黄去斑的中药面膜 | |
CN105534854A (zh) | 一种祛除鱼尾纹及眼袋的眼霜及其制备方法 | |
CN104398734A (zh) | 一种补血养颜的桑寄生口服液及其制备方法 | |
CN108992386A (zh) | 一种祛黄褐斑中药面膜及其制备方法 | |
CN106039159A (zh) | 牛皮癣中药酒 | |
CN105106712A (zh) | 一种帮助癌症患者术后恢复的营养粥及其制备方法 | |
CN105056073A (zh) | 医治心律失常的中药制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170125 |
|
RJ01 | Rejection of invention patent application after publication |